πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 308 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11253546

Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20

The Regents of the University of California Β· Granted Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11242377

Chimeric receptor with ligand binding exodomain and cytokine and T cell signalling endodom

AUTOLUS LIMITED Β· Granted Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11236161

Chimeric antigen receptors targeting CD-19

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11220535

Anti-BCMA chimeric antigen receptors

Cartesian Therapeutics, Inc. Β· Granted Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11192936

Factor VIII chimeric proteins and uses thereof

BIOVERATIV THERAPEUTICS INC. Β· Granted Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11186647

Chimeric antigen receptors targeting BCMA and methods of use thereof

LEGEND BIOTECH USA INC. Β· Granted Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11180553

Chimeric antigen receptor

AUTOLUS LIMITED Β· Granted Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11168125

Immunoglobulin chimeric monomer-dimer hybrids

BIOVERATIV THERAPEUTICS INC. Β· Granted Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11168316

Chimeric clotting factors

BIOVERATIV THERAPEUTICS INC. Β· Granted Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11160833

Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20

The Regents of the University of California Β· Granted Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11161908

BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11149073

ROR1-specific chimeric antigen receptors (CAR) with humanized targeting domains

Julius-Maximilians-Universitat Wurzburg Β· Granted Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11124541

Chimeric melanocortin ligands and methods of use thereof

Regents of the University of Minnesota Β· Granted Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11111310

Chimeric polypeptides and methods of altering the membrane localization of the same

Cell Design Labs, Inc. Β· Granted Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11103532

Chimeric protein

AUTOLUS LIMITED Β· Granted Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11091532

T cell which co-expresses a CD19 chimeric antigen receptor and a CD22 chimeric antigen rec

AUTOLUS LIMITED Β· Granted Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11077178

Chimeric antigen receptor (CAR) that targets chemokine receptor CCR4 and its use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11072644

Inhibitory chimeric antigen receptors

Allogene Therapeutics, Inc. Β· Granted Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11066674

Chimeric antigen receptors targeting b-cell maturation antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11059879

Chimeric antigen receptor molecules and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11059880

Redirected cells with MHC chimeric receptors and methods of use in immunotherapy

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11058722

Chimeric antigen receptor comprising a cartilage-oligomeric matrix protein (comp) coiled-c

AUTOLUS LIMITED Β· Granted Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11041023

Chimeric antigen receptors for phagocytosis

The Regents of the University of California Β· Granted Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11034750

Chimeric antigen receptor (CAR) comprising a CD19-binding domain

AUTOLUS LIMITED Β· Granted Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted